Unveiling the Hidden Dangers of GLP-1 Receptor Agonists
GLP-1 receptor agonists, such as semaglutide and liraglutide, have been approved for weight regulation but have been associated with rare, severe side effects. These include a higher risk of pancreatitis, intestinal obstruction, and gastroparesis. Anesthetic complications have also been reported, possibly due to slowed gastric emptying caused by the drugs. Additionally, there have been case reports of depression and suicidal ideation, prompting investigations into the potential risk of increased suicidality. Long-term safety and the possibility of side effects that may only become apparent over time are still unknown. Guidelines for the safe and effective use of these medications are currently being developed.
